| 注册
首页|期刊导航|中国医学创新|基质金属蛋白酶2,9,12与慢性阻塞性肺疾病的临床研究

基质金属蛋白酶2,9,12与慢性阻塞性肺疾病的临床研究

李敏 王宇宏 李巍

中国医学创新Issue(2):44-47,4.
中国医学创新Issue(2):44-47,4.DOI:10.3969/j.issn.1674-4985.2016.02.013

基质金属蛋白酶2,9,12与慢性阻塞性肺疾病的临床研究

Clinical Research of Matrix Metalloproteinase 2,9,12 with Chronic Obstructive Pulmonary Disease

李敏 1王宇宏 1李巍1

作者信息

  • 1. 吉林省吉林市中心医院 吉林 吉林 132011
  • 折叠

摘要

Abstract

Objective:To investigate the correlation of patients with chronic obstructive pulmonary disease(COPD) with matrix metalloproteinase2(MMP-2),matrix metalloproteinase9(MMP-9) and matrix metalloproteinase 12(MMP-12) in the serum.Method:Double-antibody sandwich method (ELISA) was used to measure the concentrations of MMP-2,MMP-9,MMP-12 in the serum of 80 patients with COPD,including acute exacerbation (AECOPD) for 40 cases and clinical remission for 40 cases.45 healthy people were selected as the healthy control group.The statistical analysis was conducted.Result:The concentrations of MMP-2,MMP-9, MMP-12 in patients with COPD were significantly higher than those of the healthy control group,the differences were statistically significant(P<0.05 orP<0.01).These index in AECOPD group were significantly higher than those in the clinical remission group(P<0.01).The concentrations of MMP-2,MMP-9,MMP-12 in stable COPD patients were passively correlated with forced expiratory volume in first second(FEV1)(r=-0.529, P<0.01;r=-0.385,P<0.05;r=-0.627,P<0.01).Conclusion:The serum level of MMP-2,MMP-9,MMP-12 in COPD patients are obviously higher,and they are positively correlated with the severity of the disease.

关键词

基质金属蛋白酶/慢性阻塞性肺疾病/第1秒用力呼气容积

Key words

Matrix metalloproteinase/Chronic obstructive pulmonary disease/Forced expiratory volume in first second

引用本文复制引用

李敏,王宇宏,李巍..基质金属蛋白酶2,9,12与慢性阻塞性肺疾病的临床研究[J].中国医学创新,2016,(2):44-47,4.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文